Heparin-Induced Thrombocytopenia: A Preventable Nosocomial Disease
نویسندگان
چکیده
ASK THE HEMATOPATHOLOGISTS – Drs. Lynch and Foucar walk through their diagnostic approach to monocytosis. MINI REVIEW – Dr. David Garcia provides an update of ACCP Guidelines for the management of venous thromboembolism. PRESIDENT’S COLUMN – ASH President Dr. Charles Abrams reports on the ASH Executive Committee Spring retreat. PROGRAM GENEALOGIES – Dr. Rainer Storb chronicles the history of the “Fred Hutch” bone marrow transplantation program. 4 6 2 13 ASH in Cuba: Unmasking Challenges and Opportunities in Hematology
منابع مشابه
Heparin induced thrombocytopenia
Abstract Background and Objectives Heparin is still a commonly used anticoagulant in prophylaxis and treatment of thromboembolic events. Heparin-induced thrombocytopenia (HIT) is a life-threating adverse drug reaction of heparin. The diagnosis of HIT is made based on two important criteria, firstly clinical evaluation and secondly laboratory testing. In this comprehensive review, the authors w...
متن کاملبروز ترومبوسیتوپنی ناشی ازهپارین، در دو روش تجویز داخل وریدی در بیماران با سندرم حاد کرونری
Incidence of Thrombocytopenia Induced by Two Methods of Intravenous Heparin injection in Patients with Acute Coronary Syndrome. H. Nough MD1* , A. Khodadadi Zadeh MSc2, M. Aref 3, A. Esmaieli Nadimi MD1 1- Assisstant Professor of Cardiology, University of Medical Sciences, Rafsanjan, Iran 2- Academic Member, Dept. of Nursing, Faculty of Nursing Midwifery, University of Medical Sci...
متن کاملA rare disease
Thrombocytopenia is a common finding in critically ill patients. Heparin-induced thrombocytopenia is an infrequent cause of a low platelet count. Intensivists should use the diagnostic classification system developed by the International Society on Thrombosis and Haemostasis to diagnose heparin-induced thrombocytopenia. The clinical relevance of the presence of anti-heparin/platelet factor 4 co...
متن کاملHeparin-induced thrombocytopenia: an update
Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized. In this review, we briefly discuss the main features of heparin-induced thrombocytopenia, particularly analyzing the most recent advances in the pathophysiology, diagnosis and treatment o...
متن کاملHeparin-induced thrombocytopenia occurring after discontinuation of heparin.
BACKGROUND Heparin-induced thrombocytopenia is caused by antibody formation to heparin-platelet factor 4 complexes. It typically develops 5 to 14 days after the initiation of heparin, but it can occur up to 3 weeks after the patient stops taking it. Early recognition by monitoring platelet counts during heparin therapy can decrease associated mortality and morbidity. METHODS A case is describ...
متن کامل